the present invention relates to new \u0434\u0435\u043d\u0434\u0440\u0438\u043c\u0435\u0440\u043d\u044b\u043c \u043a\u043e\u043d\u044a\u044e\u0433\u0430\u0442\u0430\u043c, ways of obtaining them, and their use for the treatment of diseases. the invention describes a new method of delivery \u043a\u043e\u043d\u044a\u044e\u0433\u0430\u0442\u043e\u0432 \u0434\u0435\u043d\u0434\u0440\u0438\u043c\u0435\u0440\u043e\u0432 with \u0442\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438 active molecules in the cell by the use of the proteins for \u0442\u0440\u0430\u043d\u0441\u043c\u0435\u043c\u0431\u0440\u0430\u043d\u043d wow transport of solutes in the \u0434\u0435\u043d\u0434\u0440\u0438\u043c\u0435\u0440\u043d\u044b\u0445 \u043a\u043e\u043d\u044a\u044e\u0433\u0430\u0442\u043e\u0432 on invention.the present invention is a specific object on \u043a\u043e\u043d\u044a\u044e\u0433\u0430\u0442 formula e - g - l - d (OSO3 - m + n] m, where e is a therapeutic or diagnostic effectiveness \u0442\u043e\u0440\u043d\u0443\u044e molecule, in which d (OSO3 - m + n is a dendrimer d, wherein the amount of (n \u0441\u0443\u043b\u044c\u0444\u0430\u0442\u043d\u044b\u0445 groups OSO3 - m +, where is the number of (n \u0441\u0443\u043b\u044c\u0444\u0430\u0442\u043d\u044b\u0445 groups chosen from the range. from 6 to 96.where m is a \u043a\u0430\u0442\u0438\u043e\u043d\u043d\u044b\u0439 inorganic or organic \u043f\u0440\u043e\u0442\u0438\u0432\u043e\u0438\u043e\u043d to \u0430\u043d\u0438\u043e\u043d\u043d\u043e\u0439 sulphate group, l is a linker and spacer between d and e, where g is the coupling of functional group, \u043e\u0431\u0440\u0430\u0437\u0443\u044e\u0449\u0443\u044e connection between l and e, and where m equals a number from 1 to 20.Настоящее изобретение относится к новым дендримерным конъюгатам, способам их получения и их использованию для лечения заболеваний. Изобретение описывает новый способ доставки конъюгатов дендримеров с терапевтически активными м
